⚠️ Uptrend Under Pressure Severe risk · 99 · Institutional selling is building — 6 distribution days in the last 25 sessions. · 6 distribution days (SPY) Full briefing → Jul 28
Simple research view

RVTY · Revvity, Inc.

$108.07 latest stored close
Detected setup Wyckoff SOS

Watch · Quality 22/100

Ask about RVTY

Switch to Advanced for indicator panels, raw grades, provenance, drawing tools, and full technical tables.

Scans / Health Technology / RVTY

$RVTY

Revvity, Inc.

Revvity, Inc. is a large-cap Medical Specialties company in the Health Technology sector with a market cap of $12B.

Buy · 62 Health Technology Medical Specialties stock Stage 2 · Advancing Base 1 Data 2h 0m ago
$108.07 latest close
Council read · 6 methods

Watch — evidence is building

0 buyable · 5 watch · 1 avoid. Review the observed passes and blockers before reading the chart.

Earnings-risk mode

Post-earnings setup

Monday, July 27, 2026 Time not confirmed No sourced report session or clock time

Deterministic evidence

RVTY-2.17%
Sector proxy · XLV+0.51%
Broad market · SPY+0.02%
Same completed session window ending 2026-07-27. RVTY was -2.68 points vs XLV. -2.19 points vs SPY.
CatalystUnavailable Stock reactionNegative Sector reactionSupportive Opening surgeUnavailable Event riskEarnings-driven
Price bars, sourced event fields, and benchmark math only. This can adjust displayed short-term conviction; it does not change the stored scanner score or readiness.

AI interpretation (optional)

Ask a Legend to interpret the evidence only after reviewing the deterministic event timing and relative reaction.

Interpret this evidence AI output is commentary, not scanner evidence or a sizing recommendation.
Price $108.07 Jul 27 close
52W High $118.30 -8.6%
52W Low $81.22
Wks Since High 25w
Base Depth -31.3%
Base B1
SMA 50 $104.64
SMA 200 $98.48
Avg Vol 1,440,982
RS Rank 38
RS vs High -14.4%
RS Slope -2.6% ▼
Grp Rank #48/64
ADR% 3.1%
ATR(14) $3.60 (3.3%)
Rel Vol (today) 0.94×
Vol Pace N/A
U/D Vol 0.78
A/D Days 14A / 8D
A/D Rating A+
VDU Bars 0/10 d
Earnings past
$81.22
$118.30 72%

RVTY Chart

Interactive price, volume, RS, RSI, and MACD charts are available after sign in.

Create a free account to load the full interactive chart for RVTY.

Create Free Account
Setup Quality C 3/7 signals
Jul 24: 76 (Power Play)Jul 27: 63 (Trend Only)Jul 27: 63 (Trend Only)Jul 28: 54 (Wyckoff SOS)Jul 28: 55 (Wyckoff SOS)55 Score trend
✓ Stage 2 · Advancing ✗ Power Trend ✗ RS New High ✓ Trend 7/8 ✗ No Pattern ✗ CANSLIM 57.4 (C) ✓ Gatekeeper Base #1 (A)

See the full conviction stack.

Unlock Insights

Technical Analysis Report Card

$RVTY · $108.07 · as of 2026-07-27 · multi-factor read
62
/ 100
Buy

Trend · Daily / Weekly / Monthly

Daily ▬ Sideways / consolidating
Weekly ▲ Uptrend
Monthly ▲ Uptrend

Moving Averages

50-day$104.64 ↑
100-day$97.37 ↑
200-day$98.48 ↑
Bullish (50 > 200)

RSI (14)

Reading48.9 · Neutral

Neutral — momentum is balanced between buyers and sellers.

MACD (12/26/9)

StateWeakening
Histogram-0.684

Weakening — MACD slipped below its signal line. Histogram contracting.

Bollinger Bands (20,2)

%B / Width6% · 6.4%
Squeeze — volatility compressing

Near the lower band — under pressure or oversold. Bands are squeezing — volatility is compressing, often a precursor to a sharp move.

Volume · Buyer vs Seller

Up/Down vol0.78 · Neutral
Rel volume0.94×

Balanced — up/down volume is roughly even; no clear hand. Recent volume is easing versus its baseline.

Support & Resistance

R · $116.16swing level
R · $118.3052-week high
Price · $108.07now
S · $97.23swing level
S · $93.34swing level
S · $83.56swing level

Fibonacci · Uptrend swing

23.6% ◄ price here$107.91
38.2%$102.81
50.0%$98.69
61.8%$94.57
78.6%$88.70

Retracement support zones measured from the recent swing low up to the high.

The verdict is free. The trade plan is Pro.
Unlock the exact entry, stop-loss, profit target, and reward-to-risk for RVTY — plus the full 495-symbol scanner and Ask-the-Legends chat.
🔒 Start your 7-day free trial →
Weekly uptrendMonthly uptrendAbove 200-day MA50/200 bullishRS 36 (laggard)
Want this read in a legend's voice? 💬 Ask a Legend about RVTY
Generic technical analysis generated mechanically from price & volume — educational research only, not financial advice or a personalized recommendation. Levels are illustrative; confirm on your own chart. New to these terms? →
Legend Verdicts 6 methodology checks

Who would consider this setup, why it qualifies, and what blocks it — calculated from the same deterministic methodology rules used across Legend AI.

Council consensus: 🟡 5 of 6 legends are Watching — building, not yet a confirmed buy.
Watch
Minervini C

Trend-template read: 7/12 pass; wait for the soft misses to improve.

Passing evidence
1.1 Price > 150-day MA AND 200-day MAPrice $108.07, MA150 $99.24, MA200 $98.48
1.2 150-day MA > 200-day MAMA150 $99.24 vs MA200 $98.48
Failing evidence
1.8 RS rank ≥ 70 (prefer ≥ 85)RS rank 36
2. Quarterly EPS growth ≥ 25%-37.6% QoQ
7/12 checks
Avoid
O'Neil D

CANSLIM read: fails C: Quarterly EPS acceleration ≥ 25%.

Passing evidence
N: Near 52-week high or RS line new high8.7% below high | RS line new high: False
S: Base tightness (ATR% ≤ 4.5%)ATR% 3.33%
Failing evidence
C: Quarterly EPS acceleration ≥ 25%-37.6% QoQ
L: RS rank ≥ 80 (IBD leadership)RS rank 36
2/8 checks
Watch
Weinstein C

Stage-analysis read: Stage 2 is present; 3 supporting checks need improvement.

Passing evidence
Stage 2 (Advancing phase) confirmedStage 2 (Advancing)
Price above 30-week MA (200-day proxy)Price $108.07 vs MA200 $98.48
Failing evidence
Volume expansion above averageVolume ratio 0.94x
Relative strength ≥ 60RS 36
4/7 checks
Watch
Livermore B

Pivotal-point read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$108.07
Distance from 52-week high8.7% below high
Failing evidence
Relative strengthRS 36
Volume vs average0.94x
3/6 checks
Watch
Darvas B

Box-theory read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$108.07
Distance from 52-week high8.7% below high
Failing evidence
Relative strengthRS 36
Volume vs average0.94x
3/6 checks
Watch
Wyckoff B

Supply-and-demand read: constructive evidence is present, but relative strength is unresolved.

Passing evidence
Price$108.07
Distance from 52-week high8.7% below high
Failing evidence
Relative strengthRS 36
Volume vs average0.94x
3/6 checks
Breakout Health

No active breakout tracked — Legend AI monitors daily for pivot-point breaks. What's a breakout?

RS Line vs SPY 52-week relative strength · blue = RS line · dashed = MA50 · dot = NH ▼ Falling
98RS Line (52W)
Accumulation / Distribution last 65 sessions · green = acc on high vol · red = dist on high vol Net +2 A+
A: 14 D: 12 Net: +265 sessions
Minervini · Grade Card
Fundamentals & leadership quality — Minervini SEPA criteria · 3/7 met
C 3/7 SEPA
Separate score from the 8-point Trend Template (7/8): the Trend Template grades the price structure, this grades the company & leadership (earnings, sales, margins, RS rank). A stock can ride a clean trend while its fundamentals lag, so the two often differ by design — they are not the same checklist.
EPS acceleration ≥25% QoQ -38%
Revenue growth ≥20% YoY +4%
Gross margin ≥30% 54%
ROE ≥17% 3%
RS rating ≥80 (leadership) 36
Stage 2 uptrend (Weinstein) Stage 2
Within 25% of 52W high -8.6%

Method Playbook

📋 Trade it like Wyckoff EXACT LEVELS · PRO
Minervini O'Neil Livermore Weinstein Darvas Wyckoff
Wyckoff B · Watch — The deterministic methodology check is Watch; wait for the failing or incomplete criteria to improve before the trigger can qualify.
Pivot
Pro level
Published-method rule: Use the Spring/test, Sign of Strength, creek, or Last Point of Support boundary identified by the active structure.
Evidence: Canonical setup geometry is available with Pro.
Entry trigger
Pro level
Published-method rule: Require a completed test or Sign of Strength/Last Point of Support confirmation with improving demand versus supply.
Evidence: Canonical setup geometry is available with Pro.
Initial stop
Pro level
Published-method rule: Start below the Spring/test low or structural support whose failure would invalidate the accumulation read.
Evidence: Canonical setup geometry is available with Pro.
Trail
Rule-based
Published-method rule: Raise protection beneath successive Last Points of Support or meaningful higher lows during markup; never loosen it.
Evidence: Planned management rule; no stored stop or broker order is changed automatically.
Exit / invalidation
Pro level
Published-method rule: Exit on a failed Sign of Strength, support loss, or clear supply-dominant reversal such as an upthrust failure.
Evidence: Canonical setup geometry is available with Pro.
Deterministic educational plan, not a recommendation. No order or stop is changed automatically. Method and sources →
The published-method workflow is public. Unlock exact pivot, entry, stop, target, and sizing with Pro →

Forming Patterns (predictive — not confirmed)

Cup & Handle bullish near confirmation
90% built

Cup complete, possible handle forming — watch for a quiet 5-15 bar drift on light volume holding above ~99.76 (mid-cup), then a breakout through ~116.16 on strong volume.

Confirms above 116.16
Invalidates at 99.76
Rim 118.30
Cup Low 81.22
Pivot 116.16
Mid Cup 99.76

Cup depth 31%, recovery 72%, handle=forming

Predictive pattern recognition is educational — most forming structures never confirm. Wait for the confirmation level before treating this as a setup.

Pattern Analysis

Wyckoff SOS ⚠ Extended past buy zone ⚠ Not actionable yet
54.7 score
RS Score 36
Trend 7/8
CANSLIM 57.4* (C)
range low: 85.005 range high: 100.861 range pct: 0.187 sos thrust: 0.121 sos vol ratio: 2.944 sos bars ago: 20 near lps: ✓ validation reason: valid generic setup multi tf evaluated: ✓ multi tf reason: weekly: MA stabilizing or rising — accumulation context supported
Why This Setup?
Wyckoff SOS

SOS: breakout above range_high=100.86, thrust=12.1%, vol=2.9x avg, lps=near, 20 bars ago | Strong trend (7/8) | High-confidence pattern (95%) | Stage 2 | Readiness 58/100 (early) | CANSLIM 57.4 (C) | ⚠ Extended past buy zone; Not actionable yet

The Universal Edge Check

The panel is uneasy

Too many universals unmet — this leans closer to a guess than a trade.

1/7 universals met
Why these seven? → The Universal Edge

Minervini Trend Template

7/8

Grades the price structure — moving-average stacking, distance from the 52-week high/low, and relative strength above the ≥70 uptrend bar. This is the technical trend check; the company's fundamentals and ≥80 RS leadership are scored separately in the Grade Card.

Price above SMA 150 & 200 $108.07 vs SMA150 $99.24 / SMA200 $98.48
SMA 150 above SMA 200 SMA150 $99.24 vs SMA200 $98.48
SMA 200 trending up Slope +2.43 over 20 days
SMA 50 above SMA 150 & 200 SMA50 $104.64
Price above SMA 50 $108.07 vs SMA50 $104.64
30%+ above 52W low +33.1% from $81.22
Within 25% of 52W high -8.6% from $118.30
RS score above 70 RS 36

Fundamentals

52W Range
72%
Mkt Cap SEC
12.1B
EPS QoQ
-38%
Rev YoY
+4%
ROE
3%
Gross Margin
54%
D/E
0.44
EPS TTM
$2.07
P/E TTM
52.2x
Float
112M
Insider
No Buy

Company

Legend AI snapshot
Revvity, Inc.
RVTY · NYSE · Health Technology · Medical Specialties
$108.07latest close $12.1Bmarket cap 38RS rank 55setup score
O'Neil · Grade Card
CANSLIM — current EPS, annual EPS, new highs, supply, leader RS, inst. sponsorship, market
C 57.4* CANSLIM * disqualified on C, M
C · Curr. EPS
20
A · Annual EPS
60
N · New Highs
100
S · Supply/Demand
80
L · Leader RS
36
I · Inst. Spons.
100
M · Market
30

Weekly Context

Multi-timeframe signals from weekly bars
W. Trend
8/8
W. RS
77
W. Support
$81.22
W. Resist
$118.21
Weekly Structure

Scan History

20× streak
Jul 24: 76 (Power Play)Jul 27: 63 (Trend Only)Jul 27: 63 (Trend Only)Jul 28: 54 (Wyckoff SOS)Jul 28: 55 (Wyckoff SOS)55
Jul 28
Wyckoff SOS ✓ Gate
55
Jul 28
Wyckoff SOS ✓ Gate
54
Jul 27
Trend Only ✓ Gate
63 0.0%
Jul 27
Trend Only ✓ Gate
63 0.0%
Jul 24
Power Play ✓ Gate
76 -2.2%

Get the full picture on RVTY

Pro members see entry/stop/target levels, R:R ratios, intraday alerts, and every setup detected across 495+ symbols daily.

Start 7-Day Free Trial